Home > Market Activity > Get Quotes > Company Information

Aurinia Pharmaceuticals Inc.

Exchange: TSX Exchange | Dec 13, 2018, 8:38 PM EST

AUP
$ 8.12 real time data Change Down
Change:
-0.22 (-2.64%)
Volume:
27,900
Real-time price
Day Low 8.06
Day High 8.34


Company Profile for Aurinia Pharmaceuticals Inc.

Description & Contact Information
Business Description: Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for the patients suffering from serious diseases with high unmet medical need. The firm particularly develops a therapeutic drug to treat autoimmune diseases in particular lupus nephritis. Its main product candidate is Voclosporin.
Address: 4464 Markham Street, Suite 1203, Victoria, BC, CAN, V8Z 7X8
Telephone: +1 250 744-2487 Website: http://www.auriniapharma.com
Facsimile: +1 250 744-2498 Email: dbourgeault@auriniapharma.com
Fiscal Year End: 12/2017
Industry Classifications
Sector: Healthcare CIK: 1600620
Industry: Biotechnology SIC: 3741
NAICS: Pharmaceutical Preparation Manufacturing(325412)
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges.
Market Data powered by QuoteMedia, Profiles by Morningstar. See the QuoteMedia Terms of Use.